脓毒症小鼠肠道类器官基因表达差异的转录组测序分析及髓样分化因子88抑制剂的保护作用
该研究建立C57BL/6小鼠小肠类器官,分为正常对照、LPS(200 mg/L)损伤及TJ5(10 mmol/L预处理2小时)干预三组。RT-qPCR显示LPS组IL-6 mRNA升高、ZO-1 mRNA降低,TJ5组两者趋势逆转且与LPS组差异有统计学意义。转录组测序发现LPS组49个差异基因(42上调、7下调),TJ5组84个差异基因(47上调、37下调),富集于铁死亡、谷胱甘肽代谢、细胞色素P450等通路。作者认为TJ5可能通过调控这些基因和信号通路发挥保护作用。
要点
- 在LPS 200 mg/L损伤的小鼠小肠类器官中,TJ5 10 mmol/L预处理2小时可逆转IL-6 mRNA升高(1.24±0.01 vs 1.83±0.16)和ZO-1 mRNA降低(1.97±0.29 vs 0.53±0.11),均P<0.05。
- LPS组较正常对照出现49个差异基因(42上调、7下调),TJ5组较LPS组出现84个差异基因(47上调、37下调)。
- LPS与正常对照的差异基因富集于IL-17、TNF、病毒蛋白与细胞因子及细胞因子受体相互作用、细胞因子-细胞因子受体相互作用等信号通路。
- LPS与TJ5的差异基因主要富集于动脉粥样硬化、铁死亡、谷胱甘肽代谢、细胞色素P450介导的药物代谢等信号通路。
- 作者认为TJ5可能通过调控上述基因表达及相关信号通路对脓毒症肠道损伤发挥保护作用,这些基因和通路可能是治疗脓毒症肠损伤的关键靶点。
适用人群与场景
- C57BL/6小鼠(6-8周龄)来源的小肠类器官,体外培养3天传代后用于实验。
诊断标准与关键阈值
- 类器官鉴定:免疫荧光检测Ki-67(细胞生长增殖标志)、MUC-2(杯状细胞标志)、E-cadherin(上皮细胞标志)、Lyz(潘氏细胞标志)阳性。
- 分组条件:正常对照组用含0.2% DMSO的培养基处理10小时;LPS组用含200 mg/L LPS和0.2% DMSO的培养基处理10小时;TJ5组先用10 mmol/L TJ5预处理2小时,再用含200 mg/L LPS的培养基处理10小时。
处置流程与药物剂量
- 正常对照组:含0.2% DMSO的培养基处理10小时。
- LPS组:含200 mg/L LPS和0.2% DMSO的培养基处理10小时。
- TJ5组:10 mmol/L TJ5预处理2小时,随后用含200 mg/L LPS的培养基处理10小时。
研究设计与关键结果
- 原代培养第7天形成成熟类器官,传代后生长速度增快;免疫荧光显示Ki-67、MUC-2、E-cadherin、Lyz表达,提示体外培养的小鼠小肠类器官保持细胞组成和功能特征。
- RT-qPCR:与正常对照组相比,LPS组小肠类器官IL-6 mRNA表达显著升高(2-ΔΔCT:1.83±0.16 vs 1.02±0.28,P<0.05),ZO-1 mRNA表达显著降低(2-ΔΔCT:0.53±0.11 vs 1.01±0.18,P<0.05)。
- 与LPS组相比,TJ5组IL-6和ZO-1 mRNA表达趋势均逆转,差异有统计学意义(2-ΔΔCT:IL-6 mRNA 1.24±0.01 vs 1.83±0.16,ZO-1 mRNA 1.97±0.29 vs 0.53±0.11,均P<0.05)。
- 转录组测序:LPS组较正常对照组有49个差异表达基因(42个上调、7个下调);TJ5组较LPS组有84个差异表达基因(47个上调、37个下调)。
- GO富集:正常对照组与LPS组差异基因显著富集的生物学过程包括对LPS的反应、对细菌来源分子的反应、对细菌的反应;LPS组与TJ5组差异基因显著富集的生物学过程包括谷胱甘肽代谢过程、细胞应激反应、对化学刺激的反应;分子功能方面谷胱甘肽结合和寡肽结合显著富集;细胞组分主要富集于细胞质、内质网和微粒体。
- KEGG通路富集:正常对照组与LPS组差异基因富集于IL-17信号通路、TNF信号通路、病毒蛋白与细胞因子及细胞因子受体相互作用信号通路、细胞因子-细胞因子受体相互作用信号通路;LPS组与TJ5组差异基因主要富集于动脉粥样硬化信号通路、铁死亡信号通路、谷胱甘肽代谢信号通路、细胞色素P450介导的药物代谢信号通路。
证据类型、等级与局限
- 证据类型:基础研究(小鼠小肠类器官体外实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为TJ5可能通过调控基因表达及相关信号通路(流体剪切应力与动脉粥样硬化、铁死亡、谷胱甘肽代谢、细胞色素P450药物代谢等)对脓毒症损伤的小鼠小肠类器官发挥保护作用。
- 作者认为这些基因和信号通路可能是治疗脓毒症所致肠损伤的关键靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To elucidate the molecular mechanisms underlying sepsis-induced injury in mouse intestinal organoids and investigate the possible mechanisms or potential drug targets of myeloid differentiation factor 88 inhibitor [TJ-M2010-5 (TJ5)] on this condition.
METHODS: Small intestinal organoids from C57BL/6 mice aged 6-8 weeks were established and characterized using immunofluorescence for cell growth and proliferation marker nuclear antigen Ki-67, goblet cell marker mucin-2 (MUC-2), epithelial cell marker E-cadherin, and Paneth cell marker lysozyme (Lyz). Small intestinal organoids after 3 days of passaging were divided into different groups: a normal control group treated with culture medium containing 0.2% dimethyl sulfoxide (DMSO) for 10 hours, a lipopolysaccharide (LPS) group treated with culture medium containing 200 mg/L LPS and 0.2% DMSO for 10 hours, and a TJ5 group pre-treated with 10 mmol/L TJ5 for 2 hours followed by treatment with culture medium containing 200 mg/L LPS for 10 hours. Real-time fluorescence quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was used to measure the expression levels of interleukin-6 (IL-6) and zonula occludens-1 (ZO-1) in the small intestinal organoids. RNA transcriptome sequencing was performed on the small intestinal organoids from each group to analyze differentially expressed genes between groups, and significant enrichment was analyzed using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG).
RESULTS: By the 7th day of primary culture, mature organoids had formed, and their growth rate increased after passaging. Immunofluorescence identification showed expressions of Ki-67, MUC-2, E-cadherin, and Lyz, indicating that the mouse small intestinal organoids maintained their cellular composition and functional characteristics under in vitro culture conditions. RT-qPCR results showed that compared with the normal control group, the mRNA expression of IL-6 in the small intestinal organoids of the LPS group was significantly increased (2-ΔΔCT: 1.83±0.16 vs. 1.02±0.28, P < 0.05), while the mRNA expression of ZO-1 was significantly decreased (2-ΔΔCT: 0.53±0.11 vs. 1.01±0.18, P < 0.05). In contrast, the mRNA expression trends of both IL-6 and ZO-1 were reversed in the TJ5 group, showing statistically significant differences as compared with the LPS group (2-ΔΔCT: IL-6 mRNA was 1.24±0.01 vs. 1.83±0.16, ZO-1 mRNA was 1.97±0.29 vs. 0.53±0.11, both P < 0.05). RNA transcriptome sequencing showed 49 differentially expressed genes in the LPS group compared to the normal control group, with 42 upregulated and 7 downregulated. Compared to the LPS group, the TJ5 group showed 84 differentially expressed genes, with 47 upregulated and 37 downregulated. GO enrichment analysis of these differentially expressed genes showed that the significantly enriched biological processes of the differentially expressed genes between the normal control group and the LPS group included responses to LPS, responses to molecule of bacterial origin and responses to bacterium. The significantly enriched biological processes of the differentially expressed genes between the LPS group and the TJ5 group included glutathione metabolic processes, responses to stress cellular and responses to chemical stimulus. In molecular function groups, glutathione binding and oligopeptide binding were significantly enriched by the differentially expressed genes. In cellular component classifications, the enrichment of the differentially expressed genes was mainly observed in the cytoplasm, endoplasmic reticulum, and microsomes. KEGG pathway enrichment analysis indicated that the differentially expressed genes between the normal control group and LPS group were enriched in IL-17 signaling pathways, tumor necrosis factor (TNF) signaling pathways, viral protein interactions with cytokines and cytokine receptors signaling pathways, and cytokine-cytokine receptor interaction signaling pathways. In contrast, the differentially expressed genes between the LPS and TJ5 groups were mainly enriched in atherosclerosis signaling pathways, ferroptosis signaling pathways, glutathione metabolism signaling pathways, and cytochrome P450-mediated drug metabolism signaling pathways.
CONCLUSIONS: Mouse small intestinal organoids were successfully extracted and cultured. TJ5 may exert its protective effects by regulating gene expression and related signaling pathways (fluid shear stress and atherosclerosis, ferroptosis, glutathione metabolism, cytochrome P450 drug metabolism, etc.) in sepsis-injured mouse small intestinal organoids. These genes and signaling pathways may be key targets for treating sepsis-induced intestinal injury.
参考来源
- Guo L, Xue N, Wang Q, et al. [Transcriptome sequencing analysis of gene expression differences in intestinal organoids of septic mice and the protective effects of myeloid differentiation factor 88 inhibitor]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41331886. doi:10.3760/cma.j.cn121430-20250324-00291
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。